4.8 Article

Throughput- scalable manufacturing of SARS- CoV-2 mRNA lipid nanoparticle vaccines

Related references

Note: Only part of the references are listed.
Article Biochemical Research Methods

Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery

Xu Wang et al.

Summary: A new methodology called selective organ targeting (SORT) was developed to deliver nucleic acids to specific tissues in a controlled manner. SORT lipid nanoparticles (LNPs) accurately deliver to the liver, lungs, and spleen of mice. The protocol provides detailed procedures for the synthesis of ionizable cationic lipid, preparation of SORT LNPs using various methods, physical characterization, and in vitro/in vivo mRNA delivery evaluation.

NATURE PROTOCOLS (2023)

Review Biochemical Research Methods

Principles for designing an optimal mRNA lipid nanoparticle vaccine

Edo Kon et al.

Summary: mRNA lipid nanoparticles (LNPs) have gained significant attention as therapeutic platforms due to the success of the SARS-CoV-2 mRNA LNP vaccines. The modularity and rapid manufacturing capabilities are the advantages of mRNA-LNP vaccines. When designing optimal mRNA-LNPs, choices regarding efficacy, stability, and toxicity need to be made.

CURRENT OPINION IN BIOTECHNOLOGY (2022)

Article Biochemical Research Methods

Perspectives in translating microfluidic devices from laboratory prototyping into scale-up production

Hengji Cong et al.

Summary: Transforming lab research into a sustainable business faces challenges, especially in scaling up from laboratory prototyping to industrial production. This Perspective shares insights into the manufacturing process of microfluidic cartridges and provides four suggestions to help scientists commercialize their innovations and improve the manufacturability of laboratory prototypes.

BIOMICROFLUIDICS (2022)

Article Multidisciplinary Sciences

Payload distribution and capacity of mRNA lipid nanoparticles

Sixuan Li et al.

Summary: The authors developed a method based on multi-laser cylindrical illumination confocal spectroscopy to quantitatively examine the mRNA and lipid contents in LNP formulations at the single-nanoparticle level. They revealed that a commonly referenced benchmark formulation containing DLin-MC3 as the ionizable lipid has mostly 2 mRNAs per loaded LNP and a presence of 40%-80% empty LNPs depending on the assembly conditions.

NATURE COMMUNICATIONS (2022)

Article Immunology

Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses

Mohamad-Gabriel Alameh et al.

Summary: Lipid nanoparticle (LNP)-encapsulated nucleoside-modified mRNA vaccines have intrinsic adjuvant activity that enhances durable and protective antibody responses. Compared to the widely used MF59-like adjuvant AddaVax, this LNP formulation outperforms and relies on specific components and cytokine induction for its adjuvant activity.

IMMUNITY (2021)

Article Multidisciplinary Sciences

An ionizable lipid toolbox for RNA delivery

Xuexiang Han et al.

Summary: In recent years, RNA therapeutics has seen significant growth, largely due to decades of research on lipid nanoparticles, particularly its key component - ionizable lipid. This commentary discusses the major types of ionizable lipids and offers perspectives for future development.

NATURE COMMUNICATIONS (2021)

Review Immunology

mRNA vaccines manufacturing: Challenges and bottlenecks

Sara Sousa Rosa et al.

Summary: mRNA vaccines are emerging as a new alternative to conventional vaccines, with their precision, safety profile, and flexible manufacturing. They have been used to combat the Covid-19 pandemic and are being studied for other diseases as well. However, challenges in manufacturing, technology platform, and cost-effective production need to be addressed to fully utilize this new vaccination technology.

VACCINE (2021)

Review Engineering, Biomedical

Microfluidic formulation of nanoparticles for biomedical applications

Sarah J. Shepherd et al.

Summary: Nanomedicine has advanced significantly in clinical applications, with microfluidic devices showing potential for generating reproducible nanoparticle formulations. These formulations enhance biomedical applications with controlled physical properties, pointing towards future production scale-independent formulations through parallelization and multi-step reactions.

BIOMATERIALS (2021)

Article Chemistry, Multidisciplinary

Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device

Sarah J. Shepherd et al.

Summary: The study presents a scalable, parallelized microfluidic device (PMD) that can simultaneously operate 128 mixing channels, achieving over 100 times production rate compared to traditional methods for lipid nanoparticles (LNPs). Results demonstrate superior delivery of LNPS generated using PMD in mice, showing potential for emerging clinical applications such as RNA therapeutics and vaccines.

NANO LETTERS (2021)

Review Physics, Applied

Scaling up the throughput of microfluidic droplet-based materials synthesis: A review of recent progress and outlook

Jingyu Wu et al.

Summary: In the past two decades, significant advancements have been made in the development of microfluidic chips for generating micrometer- and nanometer-scale materials, with vast potential applications in various fields. However, the throughput of these chips is limited by the physics of multiphasic flows in micro-channels, resulting in low production rates for practical applications. Recent progress has been made in designing chip architectures with multiple microfluidic devices to increase throughput while maintaining the benefits of microfluidic particle generation.

APPLIED PHYSICS REVIEWS (2021)

Review Nanoscience & Nanotechnology

Lipid nanoparticles for mRNA delivery

Xucheng Hou et al.

Summary: Lipid nanoparticle-mRNA formulations have successfully entered clinical use as COVID-19 vaccines, representing a major milestone in mRNA therapeutics. This review discusses the design of lipid nanoparticles for mRNA delivery, emphasizing key points for clinical translation and preclinical studies of lipid nanoparticle-mRNA therapeutics for various diseases.

NATURE REVIEWS MATERIALS (2021)

Review Immunology

Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines

Mohammad N. Uddin et al.

Summary: In response to the emergence of COVID-19, mRNA-based vaccines by Moderna and BioNTech/Pfizer have been identified as the most effective ones. However, the global use of these vaccines is limited by ultracold storage requirements. Therefore, finding strategies to increase stability of mRNA-based vaccines in relatively higher temperatures is crucial to address the current global pandemic and upcoming new waves.

VACCINES (2021)

Article Materials Science, Biomaterials

Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver

Rui Zhang et al.

Summary: Nucleic acids hold promise for treating 'undruggable' diseases, but face challenges in delivery due to biological barriers. Research found that LNPs with different formulations preferentially accumulate in the liver and spleen, impacting nucleic acid delivery. Understanding the role of helper lipids and ApoE in LNP distribution may help in designing effective nucleic acid therapeutics.

BIOMATERIALS SCIENCE (2021)

Article Chemistry, Multidisciplinary

Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering

Margaret M. Billingsley et al.

NANO LETTERS (2020)

Article Pharmacology & Pharmacy

Using microfluidics for scalable manufacturing of nanomedicines from bench to GMP: A case study using protein-loaded liposomes

Cameron Webb et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)

Article Nanoscience & Nanotechnology

Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing

Qiang Cheng et al.

NATURE NANOTECHNOLOGY (2020)

Editorial Material Biotechnology & Applied Microbiology

The COVID-19 vaccine development landscape

Tung Thanh Le et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Review Immunology

Recent advances in mRNA vaccine technology

Norbert Pardi et al.

CURRENT OPINION IN IMMUNOLOGY (2020)

Article Pharmacology & Pharmacy

Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics

Carla B. Roces et al.

PHARMACEUTICS (2020)

Article Multidisciplinary Sciences

Robust Microfabrication of Highly Parallelized Three-Dimensional Microfluidics on Silicon

Sagar Yadavali et al.

SCIENTIFIC REPORTS (2019)

Article Chemistry, Multidisciplinary

Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening

Pedro P. G. Guimaraes et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Review Biotechnology & Applied Microbiology

Nanoparticles in the clinic: An update

Aaron C. Anselmo et al.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2019)

Article Chemistry, Multidisciplinary

On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA

Jayesh A. Kulkarni et al.

ACS NANO (2018)

Article Chemistry, Multidisciplinary

Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA

Rebecca L. Ball et al.

NANO LETTERS (2018)

Review Biotechnology & Applied Microbiology

mRNA vaccines - a new era in vaccinology

Norbert Pardi et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

Article Chemistry, Multidisciplinary

Phase behaviour of disordered proteins underlying low density and high permeability of liquid organelles

Ming-Tzo Wei et al.

NATURE CHEMISTRY (2017)

Article Nanoscience & Nanotechnology

Clogging in parallelized tapered microfluidic channels

Sorell S. Massenburg et al.

MICROFLUIDICS AND NANOFLUIDICS (2016)

Article Biotechnology & Applied Microbiology

Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo

Hao Yin et al.

NATURE BIOTECHNOLOGY (2016)

Article Chemistry, Physical

Microfluidic Mixing: A General Method for Encapsulating Macromolecules in Lipid Nanoparticle Systems

Alex K. K. Leung et al.

JOURNAL OF PHYSICAL CHEMISTRY B (2015)

Review Biotechnology & Applied Microbiology

Application of process analytical technology for downstream purification of biotherapeutics

Anurag S. Rathore et al.

JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY (2015)

Article Nanoscience & Nanotechnology

Parallel microfluidic synthesis of size-tunable polymeric nanoparticles using 3D flow focusing towards in vivo study

Jong-Min Lim et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)

Article Biochemical Research Methods

Hybrid soft-lithography/laser machined microchips for the parallel generation of droplets

M. Muluneh et al.

LAB ON A CHIP (2013)

Article Pharmacology & Pharmacy

Advances in Lipid Nanoparticles for siRNA Delivery

Yuen Tam et al.

Pharmaceutics (2013)

Article Chemistry, Multidisciplinary

Rapid Discovery of Potent siRNA-Containing Lipid Nanoparticles Enabled by Controlled Microfluidic Formulation

Delai Chen et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)

Article Biochemical Research Methods

High throughput production of single core double emulsions in a parallelized microfluidic device

Mark B. Romanowsky et al.

LAB ON A CHIP (2012)

Review Nanoscience & Nanotechnology

Microfluidic technologies for accelerating the clinical translation of nanoparticles

Pedro M. Valencia et al.

NATURE NANOTECHNOLOGY (2012)

Review Biochemistry & Molecular Biology

Developing mRNA-vaccine technologies

Thomas Schlake et al.

RNA BIOLOGY (2012)

Article Medicine, Research & Experimental

Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA

Nathan M. Belliveau et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2012)

Article Chemistry, Multidisciplinary

Microfluidic Mixing and the Formation of Nanoscale Lipid Vesicles

Andreas Jahn et al.

ACS NANO (2010)

Article Multidisciplinary Sciences

Lipid-like materials for low-dose, in vivo gene silencing

Kevin T. Love et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Physics, Fluids & Plasmas

Mechanism for clogging of microchannels

Hans M. Wyss et al.

PHYSICAL REVIEW E (2006)

Article Multidisciplinary Sciences

RNAi-mediated gene silencing in non-human primates

TS Zimmermann et al.

NATURE (2006)

Article Chemistry, Multidisciplinary

A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA

LB Jeffs et al.

PHARMACEUTICAL RESEARCH (2005)

Article Multidisciplinary Sciences

Chaotic mixer for microchannels

AD Stroock et al.

SCIENCE (2002)